Condensed Consolidated Statements Of Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 25, 2012		Mar. 27, 2011
Cash flows from operating activities:
Net income	$ 20,742		$ 27,111
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	5,216		5,606
Gains on sale/disposal of assets	(37)		(1,624)
Amortization of deferred financing costs, debt discount and other	9,824		1,424
Provision for deferred income taxes	4,821		9,033
Non-cash compensation expense	4,290		3,008
Tax impact from equity-based compensation	(6,537)		(6,624)
Other	(197)		556
Changes in operating assets and liabilities	(17,905)		(10,681)
Net cash provided by operating activities	20,217		27,809
Cash flows from investing activities:
Capital expenditures	(3,634)		(3,870)
Proceeds from sale of assets	508		3,249
Changes in restricted cash	45,341		767
Other	237		148
Net cash provided by investing activities	42,452		294
Cash flows from financing activities:
Proceeds from issuance of long-term debt	1,575,000
Repayments of long-term debt and capital lease obligations	(1,447,127)		(226)
Proceeds from issuance of common stock			435
Proceeds from exercise of stock options	1,202		16,827
Tax impact from equity-based compensation	6,537		6,624
Purchase of common stock			(5,839)
Tax payments for restricted stock	(1,863)		(1,171)
Cash paid for financing costs	(31,197)
Net cash provided by financing activities	102,552		16,650
Effect of exchange rate changes on cash and cash equivalents	(783)		(114)
Change in cash and cash equivalents	164,438		44,639
Cash and cash equivalents, at beginning of period	50,292	[1]	47,945
Cash and cash equivalents, at end of period	$ 214,730		$ 92,584

[1] The balance sheet at January 1, 2012 has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.